Biotech ETFs Could Be in for More Pain Ahead
After suffering one of their worst Aprils in years, biotech sector-related exchange traded funds could be in for even more pain ahead.
Source: etftrends.com
Stay updated with breaking news from Will Sevush. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
After suffering one of their worst Aprils in years, biotech sector-related exchange traded funds could be in for even more pain ahead.